SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction

SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction

Heart failure (HF) is a major health problem with a significant impact on morbidity, mortality, quality of life and healthcare costs. Despite the positive impact of disease-modifying therapies developed over the last four decades, HF mortality and hospitalization remain high.We aim at reviewing the...

Full description

Bibliographic Details
Main Authors: José Silva-Cardoso, Aurora Andrade, Dulce Brito, Jorge Ferreira, Cândida Fonseca, Marisa Peres, Fátima Franco, Brenda Moura
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Revista Portuguesa de Cardiologia (English Edition)
Subjects:
Inibidores do SGLT-2
Insuficiência cardíaca
Diabetes mellitus tipo 2
Dapagliflozina
Empagliflozina
Canagliflozina
Online Access:http://www.sciencedirect.com/science/article/pii/S2174204921002518

Internet

http://www.sciencedirect.com/science/article/pii/S2174204921002518

Similar Items